Articles

mesh

Community engagement in health systems interventions and research in conflict-affected countries: a scoping review of approaches

by Anna Durrance-Beagle, Manar Marzouk, Lam Sze Tung, Sunanda Agarwal,, Zeenathnisa Mougammadou Aribou, Nafeesah Bte Mohamed Ibrahim, Hala Mkhallalati, Sanjida Newaz,, Maryam Omar, Mengieng Ung, Ayshath Zaseela, Michiko Nagashima-Hayashi, Natasha Howard

  Health research and service delivery are often planned and implemented with little direct involvement from the communities they are intended to support, which can result in poor use of ...

mesh

Community engagement in health systems interventions and research in conflict-affected countries: a scoping review of approaches

by Anna Durrance-Beagle, Manar Marzouk, Lam Sze Tung, Sunanda Agarwal,, Zeenathnisa Mougammadou Aribou, Nafeesah Bte Mohamed Ibrahim, Hala Mkhallalati, Sanjida Newaz, Maryam Omar,

Health research and service delivery are often planned and implemented with little direct involvement from the communities they are intended to support, which can result in poor use of resources, ...

News

CEPI launches new Biosecurity Policy

CEPI has published its first Biosecurity Policy, strengthening safe, responsible, and equitable research. The Policy outlines clear biosecurity and biosafety requirements for Third Parties, supporting our mission to advance global health preparedness and protect communities through secure scientific innovation. Read more

CEPI launches a Call for Proposal for innovative analytical technologies to improve vaccine manufacturing speed and equitable access

Deadline for application: 1 May 2026. An application may be submitted at any time; the review process will involve quarterly reviews throughout the 12-month application period

CEPI has announced a funding opportunity to develop innovative analytical technologies for vaccines. The goal is to reduce vaccine development, manufacturing, and release times; lower costs, improve equitable deployment in Low to Middle-Income Countries, and enhance analytical insights for vaccines. Read more

Announcing the Lassa Fever Vaccine Policy Research Agenda

The publication of the first-ever Lassa Fever Vaccine Policy Research Agenda is a landmark achievement for regional health security and vaccine preparedness in West Africa

It aims to guide researchers, funders, and policymakers in aligning ongoing and future studies with the most pressing policy needs. The agenda also aims to strengthen coordination and ensure that new evidence directly informs national and regional vaccine readiness decisions. Read more

CEPI has launched the Research Preparedness Program (RPP)

The RPP will support both advanced-stage clinical development of CEPI’s portfolio vaccines against priority diseases and the 100 Days Mission

The objective of the RPP is to leverage investments for advanced-stage clinical development of CEPI's portfolio vaccines and support countries in key regions to generate emergency evidence in future outbreaks Read more

Older News Here |